期刊文献+

肺癌肉瘤13例临床分析 被引量:4

Clinical Manifestation of Thirteen Pulmonary Carcinosarcoma
下载PDF
导出
摘要 目的分析肺癌肉瘤的临床表现及特点,探讨肺癌肉瘤的预后因素及治疗方式。方法对13例肺癌肉瘤患者的临床资料,采用SPSS 18.0统计学软件进行数据分析,应用Kaplan-Meier法计算其生存率(overall survival rate,OS),并进行单因素分析。结果 13例肺癌肉瘤中,癌成分为鳞癌7例、腺癌4例(其中1例合并小细胞癌)、腺鳞癌1例、未分化癌1例。淋巴结转移以癌成分为主。单因素分析结果显示,肺癌肉瘤癌成分(P=0.047)及手术方式(P=0.019)是影响其预后的因素。结论肺癌肉瘤是肺肉瘤样癌的1种亚型,包含癌成分及肉瘤成分,其中癌成分为鳞癌者预后好于非鳞癌者(P=0.047);根治性手术是治疗肺癌肉瘤的主要方法,肺癌肉瘤术后易发生远处转移,发生远处转移后采用综合治疗,有利于提高患者远期生存率。 Objective This study was to analyze the clinical features and characteristics of pulmonary carcinosarcoma,and investigate the prognostic factors and treatment of this tumor.Methods The clinical data of pulmonary carcinosarcoma were analyzed using SPSS 18.0 software.The Overall survival rates(OS) and the prognostic factors were calculated and compared with the Kaplan-Meier method and the Log-rank test.Results Among all the 13 patients included,the carcinomatous component of carcinosarcoma was different,7 were squamous cell carcinoma,4 were adenocarcinoma(one included small cell carcinoma),1 were adenosquamous carcinoma and 1 were undifferentiated carcinoma.The carcinomatous component appears more frequently in local lymph node metastasis.In single-factor prognostic analysis,histologic pattern of the carcinomatous component(P=0.047) and the character of operation(P=0.019) were the prognostic factor.Conclusion Pulmonary carcinosarcoma is one type of pulmonary sarcomatoid carcinoma,consisting of both carcinomatous component and sarcomatous component,while the carcinomatous component with squamous cell carcinoma had a better prognosis than non-squamous carcinoma(P=0.047).We conclude that radical resection of this tumor may achieve good prognosis.Distant metastasis was more often to appear,but comprehensive treatment was extremely needed to improve the long-time survival.
出处 《实用癌症杂志》 2012年第5期506-509,共4页 The Practical Journal of Cancer
关键词 肺癌肉瘤 梭形细胞肉瘤 临床特征 预后 治疗 Pulmonary carcinosarcoma; Spindle cell carcinosarcoma; Clinical features; Therapy; Prognosis
  • 相关文献

参考文献13

  • 1Travis WD, Colby TV, Corrin B, et al. Histological typing of lung and pleural tumors. World Health Organization classifi- cation of tumors [ M ]. 3rd edition. Berlin; Springer, 1999 : 310.
  • 2Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pa- thology and genetics of tumours of the lung, pleura, thymus and heart. World Health Organization classification of tumours [ M ]. 4th edition. Lyon ; IARC Press, 2004:53.
  • 3Davis MP, Eagan RT, Weiland LH, et al. Mayo Carcinosar- coma of the lung : Clinic experience and response to chemo- therapy[J]. Mayo Clin Proc ,1984,59:598.
  • 4Cabarcos A, Gomez Dorronsoro M, Lobo Beristain JL . Pul- monary earcinosareoma : a case study and review of the liter- ature[J]. Br J Dis Chest, 1985,79 : 83.
  • 5Shuichi Sato, Temaki Koike, Yasushi Yamato, et al. A case of rapidly growing pulmonary earcinosarcoma[J]. Int J Clin Onco1,2010,15:319.
  • 6Marfa Jesfis Vidal Losada, Vanessa Bernal Monterde, Beat- riz Amores Arriaga, et al. Lung carcinosarcoma[J]. Clin Transl Oncol,2010,12:303.
  • 7王永岗,张汝刚,张德超,汪良骏,张大为.原发性肺肉瘤的外科治疗[J].实用癌症杂志,2003,18(3):282-284. 被引量:13
  • 8Huwer H, Kalweit G, Straub U, et al. Pulmonary carcinosar- coma : diagnostic problems and determinants of the prognosis[J].Eur J Cardiothorac Surg, 1996,10 (6) :403.
  • 9高禹舜,邢学忠,邵康,冯晓莉,赫捷.1826例非小细胞肺癌的预后因素分析[J].中华肿瘤杂志,2008,30(2):134-137. 被引量:16
  • 10王永岗,汪良骏,张德超,张宏图,张汝刚,张大为.肺癌肉瘤12例临床分析[J].中国肿瘤临床,2000,27(9):660-662. 被引量:16

二级参考文献39

  • 1高禹舜,张德超,赫捷,孙克林,张大为,张汝刚.Ⅰ期非小细胞肺癌的诊断与外科治疗[J].中华肿瘤杂志,2005,27(1):52-55. 被引量:16
  • 2蔡执敏,蔡廉甫.肺癌肉瘤三例报告并文献复习[J].中华结核和呼吸杂志,1989,12(3):164-166. 被引量:8
  • 3徐志龙,丁嘉安,石美鑫,徐正良,谢秀华.肺部罕见恶性肿瘤——癌肉瘤(附15例临床分析)[J].中华肿瘤杂志,1996,18(2):119-122. 被引量:32
  • 4熊丽纹,顾爱琴,白皓,纪灏,戚大江,廖美琳,周允中,赵家美,韩宝惠.可手术非小细胞肺癌多学科治疗对预后因素的影响[J].中国癌症杂志,2006,16(3):193-197. 被引量:14
  • 5Poleri C, Morevo JL, Nieva B, et al. Risk of recurrence in palients with surgically resected stage Ⅰ non-small cell lung carcinoma: histopathologic and immunohistochemical analysis. Chest, 2003, 123 : 1858-1867.
  • 6Mountain CF. Revisions in the International System for Slaging Lung Cancer. Chest, 1997, 111:1710-1717.
  • 7Collins LG, Haines C, Perkel R, et al. Lung cancer: diagnosis and management. Am Faro Physician, 2007, 75:56-63.
  • 8DouiUant JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin remus observation in patients with completely resected stage Ⅰ B-Ⅲ A non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ ANITA ]): a randomised controlled trial. Lancet Oncol, 2006, 7:719-727.
  • 9Gabor S, Renner H, Popper H, et al. Invasion of blood vessel as significant prognostic factor in radically resected T1-3N0M0 nonsmall-cell lung cancer. Eur J Cardiothorac Surg, 2004, 25:439- 442.
  • 10Ichinose Y, Yano T, Asoh H, et al. Prognostic factors obtained by a pathologic examination in completely resected non-small cell lung cancer: an analysis in each pathologic stage. J Thorac Cardiovasc Stag, 1995, 110:601-605.

共引文献55

同被引文献32

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部